A screening and identification method of ech1 autoantibody and its application
An autoantibody and identification method technology, applied in the field of ECH1 autoantibody screening and identification, can solve the problem of unsatisfactory tumor markers, and achieve the effects of low cost, high accuracy and simple operation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0019] The technical solution of the present invention will be described in further detail below in conjunction with the accompanying drawings and specific embodiments.
[0020] The present invention adopts serum proteomics technology (such as figure 1 ) to screen lung cancer-associated tumor antigens, and use ELISA to detect the level of ECH1 antibody in the serum of lung cancer patients.
[0021] 1) Two-dimensional electrophoresis was performed on the whole protein extract of the lung cancer cell line H1299, and western blotting was performed with the sera of 5 lung cancer patients and 5 normal human sera to screen meaningful tumor autoantigens. After comparison and analysis, they only appeared in the serum of patients The protein spots were further analyzed (such as figure 2 ).
[0022] 2) After the protein spot of interest on the SDS-PAGE gel was cut and digested, the above protein spot was analyzed by LC-MS / MS mass spectrometry method, and it was identified as ECH1 aft...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com